| Financial Year |
March 31 2023 |
| Monetary Funds |
24,139,164.28 |
| Held-for-trading Financial Assets |
4,167,035.54 |
| Notes Receivable |
-- |
| Accounts Receivable |
744,016,629.64 |
| Advances to Suppliers |
24,016,129.91 |
| Other Receivables |
52,236,614.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,174,880.00 |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,437,437.47 |
| Total Current Assets |
875,811,930.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
76,843,406.76 |
| Investment Properties |
5,638,212.50 |
| Fixed Assetes |
4,876,160.67 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
13,652,719.51 |
| R&D expenses |
188,525.63 |
| Goodwill |
53,347,464.17 |
| Long-Term Deferred and Prepaid Expenses |
14,710,647.35 |
| Deferred Income Tax Assets |
45,022,688.78 |
| Other Non-Current Assets |
8,375,000.00 |
| Sub-Total of Non-Current Assets |
235,861,011.99 |
| Total Assets |
1,111,672,942.51 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
609,982,190.95 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,167,208.14 |
| Taxes Payable |
6,512,918.49 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,518,481.10 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,622,391.89 |
| Other Current Liabilities |
32,408,789.40 |
| Sub-Total of Current Liabilities |
672,343,647.28 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
220,728,935.85 |
| Deferred Income Tax Liabilities |
3,016,350.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
229,874,335.19 |
| Total Liabilities |
902,217,982.47 |
| Paid-In Capital(Or Share Stock) |
922,347,736.00 |
| Capital Surplus |
283,787,144.74 |
| Surplus Reserve |
35,442,366.75 |
| LESS:Treasury Stock |
47,356,777.65 |
| Undistributed Profits |
-978,804,998.01 |
| Minority Stockholder's Interest |
-3,705,121.72 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
213,160,081.76 |
| Owner's Equity（Stockholder's Equity） |
209,454,960.04 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,111,672,942.51 |
